CD4 and metastatic carcinoma: The Class II MHC Transactivator (CIITA) is an MHC II trans-activating factor supporting CD4 + T-Lymphocyte recruitment; thus, the downregulation of CIITA was reported to be related to aggressive and metastatic carcinoma [35].